Ligand Pharmaceuticals (NASDAQ: LGND) disclsoed that on May 17, 2013 its Research License and Option Agreement with ARES Trading SA ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE